HYPER RHO S/D FULL DOSE, HYPER RHO

SECTION 2: Hazards identification

29 CFR 1910.1200) Globally Harmonized System of Classification and Labeling of Chemicals (GHS) No hazards are expected from using this product. This p roduct is not regulated under the United Nations Globally Harmonized System for the Classification and Labeling of Hazardous Chemicals (GHS) 2006 version; European Directive 67/648/EEC; and U.S OSHA 29 CFR 1910.1200 Hazard Communication Standard. Alth ough a SDS is not required, this document is offered as a s ervice to customers who handle or might come in contact with this product and would like guidance. Emergency Overview: This product poses little or no hazard if spilled and no unusual hazard is expected if involved in a fire.

EU Classification

The product is not regulated under European Directive 67/648/EEC OSHA CLASSIFICATION: The product is not regulated under U.S. OSHA 29 CFR 1910.1200 (Hazard Co mmunication S tandard). P HYSICAL FORM: Liquid COLOR: Col orless to pale yellow to pink ODOR: Odorless None

Principle Routes of Exposure

Accidental Eye contact, Skin contact, Ingestion; Appropriate route of entry Intramuscular MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: None known

Potential health effects

INHALATION: ACUTE (IMMEDIATE): None known CHRONIC (DELAYED): None kno wn SKIN: ACUTE (IMMEDIATE): None known CHRONIC (DELAYED): None known EYE: ACUTE (IMMEDIATE): None known CHRONIC (DELAYED): None known INGESTION ACUTE (IMMEDIATE): None known CHRONIC (DELAYED): None known MUTAGENIC E FFECTS: None known CARCINOGENIC EFFECTS: None kno wn REPRODUCTIVE EFFECTS: None know n Page 2 of 6 HYPER RHO® S/D

Other Health Effects

This product is prepared from pooled human plasma. Each plasma donation has been tested for the absence of antibodies ag ainst HIV-1, HIV-2 and Hepatitis C and the absence of surface antigens for H epatitis B. Additionally, mini-pools of plasma donations have been tested for the absence of the HIV-1, Hepatitis C and Hepatitis B viruses using Polymera se Chain Reaction (PCR) technology. The product has also undergone s eparate manufacturing processes to remove and/or inactivate enveloped and non-enveloped viruses. However, as with all human derived products, the risk of infectivity due to known or yet unknown pathogens cannot be totally eliminated or ensured. See Section 12 for Ecological Information